Vizient has ranked Rush University Medical Center #1 for quality among the nation’s most prestigious academic medical centers. Learn more.

Excellence is just the beginning.


French German Italian Portuguese Russian

Post Surgery Pain Mangagement Drug Treatment Study

Clinical Trial Title: 
A phase 3, randomized, double-blind, placebo-controlled, multicenter, evaluation of the safety of N1539 following major surgery.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Adam C. Young, MD
Clinical Trial Protocol Description: 

The purpose of this study is to test a study drug for safety and pain management after an elective surgery.

Clinical Trial Eligibility Criteria: 

In order to participate you must be having surgery which would require a 48 hour hospitalization and not be pregnant or breastfeeding.

You will be excluded from the study if any of the following criteria apply to you:

  • Are HIV positive.
  • Have cancer.
  • Have a known bleeding disorder.
  • Have a history of alcohol abuse.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Pain Management
Contact Phone: 
(312) 942-2985
Contact Name: 
Sherry Robison